glutathione peroxidase 2 antibody Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment Cited in 15 publications Anti-Glutathione Peroxidase 2/GPX2 antibody [EPR8175(2)]
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
![glutathione peroxidase 2 antibody Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment Cited in 15 publications Anti-Glutathione Peroxidase 2/GPX2 antibody [EPR8175(2)]](https://content.abcam.com/products/images/glutathione-peroxidase-2-gpx2-antibody-epr81752-bsa-and-azide-free-ab248890--western-blot-img124460.jpg)
![glutathione peroxidase 2 antibody Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment Cited in 15 publications Anti-Glutathione Peroxidase 2/GPX2 antibody [EPR8175(2)]](https://assets.fishersci.com/TFS-Assets/CCG/Novus-Biologicals/antibodies/nbp3-21495mfv450_mouse-trem1-mab-6b1-mfluor-violet-450-se-2762023915140.jpg-650.jpg)
![glutathione peroxidase 2 antibody Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment Cited in 15 publications Anti-Glutathione Peroxidase 2/GPX2 antibody [EPR8175(2)]](https://www.raybiotech.com/media/catalog/product/cache/362ba88fcdc93074e3517f26c69022c1/a/n/antibody_cartoon_sm.gif)
![glutathione peroxidase 2 antibody Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment Cited in 15 publications Anti-Glutathione Peroxidase 2/GPX2 antibody [EPR8175(2)]](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42269-024-01250-x/MediaObjects/42269_2024_1250_Sch1_HTML.png)
![glutathione peroxidase 2 antibody Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment Cited in 15 publications Anti-Glutathione Peroxidase 2/GPX2 antibody [EPR8175(2)]](https://assaypro.com/wp-content/uploads/32288-05141f.jpg)























